State-of-the-art in minimally invasive treatments for benign prostatic obstruction
Investigative and Clinical Urology · 2026 · 67 (1) · 1
DOI: 10.4111/icu.20250390 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative and Clinical Urology, 2026. Verfasst von Nico C Grossmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital Southampton NHS Trust, Southampton, United Kingdom. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Minimally Invasive Surgical Procedures, Lower Urinary Tract Symptoms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Benign prostatic obstruction (BPO), often caused by benign prostatic hyperplasia (BPH), significantly affects quality of life in aging men. While transurethral resection of the prostate remains a standard surgical treatment, its invasiveness and associated side effects have led to the development of minimally invasive surgical therapies (MIST) as alternatives. This narrative review summarizes current evidence on established and emerging MIST options, including Rezum, iTind, UroLift, CoreTherm, TPLA (transperineal laser ablation), Optilume BPH, and new stent-based, first-line interventional therapies (FITs), such as Zenflow Spring, Butterfly, ProVee System, Urocross, and FloStent. These therapies aim to relieve lower urinary tract symptoms with fewer complications, reduced recovery time, and better preservation of sexual function. Each technique varies in mechanism-thermal, mechanical, or pharmacological-and is suited to specific prostate anatomies and patient profiles. Clinical data support their efficacy in improving International Prostate Symptom Score, peak urinary flow rate, and quality of life scores, with durability ranging from one to five years depending on the modality. Adverse events are generally mild and transient, while rates of ejaculatory and erectile dysfunction remain low across most interventions. FITs offer potential for temporary or long-term decompression with minimal procedural requirements. Overall, MIST broaden the therapeutic landscape for men with symptomatic BPO, particularly those who are unfit or unwilling to undergo conventional surgery. As the field evolves, these interventions contribute to a more personalized, function-preserving approach in BPH management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, University Hospital Southampton NHS Trust, Southampton, United Kingdom.
- Clinic for Urology, University Teaching and Research Hospital of the University of Lucerne, Lucerne, Switzerland.
- Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
- Division of Urology, Department of Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
- Department of Urology, UROSUD, Clinique La Croix du Sud, Quint-Fonsegrives, France.
ORCID-Profile: Nico C Grossmann, Mohamad B Berjaoui, Benjamin Pradere, Bhaskar K Somani, Dean S Elterman
Zitieren
APA
Grossmann, N. C., Berjaoui, M. B., Choudhary, O., Pradere, B., Somani, B. K., & Elterman, D. S. (2026). State-of-the-art in minimally invasive treatments for benign prostatic obstruction. Investigative and Clinical Urology, 67(1), 1. https://doi.org/10.4111/icu.20250390
Vancouver
Grossmann NC, Berjaoui MB, Choudhary O, Pradere B, Somani BK, Elterman DS. State-of-the-art in minimally invasive treatments for benign prostatic obstruction. Investigative and Clinical Urology. 2026;67(1):1. doi:10.4111/icu.20250390
BibTeX
@article{Grossmann2026,
author = {Grossmann, Nico C and Berjaoui, Mohamad B and Choudhary, Omer and Pradere, Benjamin and Somani, Bhaskar K and Elterman, Dean S},
title = {State-of-the-art in minimally invasive treatments for benign prostatic obstruction},
journal = {Investigative and Clinical Urology},
year = {2026},
volume = {67},
number = {1},
pages = {1},
doi = {10.4111/icu.20250390}
}
EUVIMED